InvestorsHub Logo
Followers 127
Posts 17932
Boards Moderated 0
Alias Born 10/27/2006

Re: SanDiegoAlan post# 1388

Friday, 02/10/2017 2:23:38 PM

Friday, February 10, 2017 2:23:38 PM

Post# of 3630
From the 8k: On February 7 2017 Regen Biopharma, Inc. ( “Licensor”) entered into an agreement (“Agreement”) with Checkpoint Immunology, Inc. (“Licensee”) whereby Licensor granted to Licensee an exclusive worldwide right and license for the development and commercialization of certain intellectual property controlled by Licensor (“ License IP”) for human therapeutic use. Licensee is a wholly owned subsidiary of Licensor.

RGBP owns them 100%

Hit the ask early and often!

TRAZ